Harnessing the Microbiome for Drug Discovery: the Example of a Microbiome-Derived Therapeutic for Ulcerative Colitis
Time: 11:45 am
day: Day 2 - Track B Afternoon
Details:
- Microbiome-derived IL-10 inducer on specific bioassays
- Characterization and preclinical validation of EB1010
- Intended clinical development of EB1010 in Ulcerative Colitis
